What You Should Know:
– H1, the largest database of information on every doctor in the world raises $58M in Series B funding, just six months after raising its Series A round during the pandemic.
– H1 is the largest database in the world connecting that provides comprehensive in-depth profiles of more than 9 million healthcare professionals and 16,000 institutions in 70-plus countries, all of which are kept up-to-date weekly.
H1, a global platform for the healthcare ecosystem, announced today that it has closed a $58 million Series B round of funding co-led by IVP and Menlo Ventures, which led the Series A round in April 2020. Transformation Capital, Lux Capital, Lead Edge Capital, Novartis dRx and YC also participated.
Over 9 Million Healthcare Professional Profiles
Co-founded by Ariel Katz and Ian Sax in 2017, H1 is a developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. H1 has created the largest healthcare platform to forge connections in the healthcare ecosystem. The H1 team has taken a unique approach to building the platform that combines AI, human-powered engineering, third-party data sources, and government partnerships, to create the largest platform of healthcare professionals, currently spanning over 9 million healthcare professions around the globe.
The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.
H1 has enjoyed tremendous growth in 2020, surpassing projections and proving the need for its platform of doctors is stronger than ever. Following its Series A announcement in April 2020 of $12.9 million, the company has grown from approximately 100 employees globally to nearly 250 and anticipates expanding its headcount significantly over the next year, including further expansion into Europe and Asia.
With over 50+ customers to date and growing rapidly, H1 is slowly becoming the standard that companies think about when they want to find the right Key Opinion Leading Doctors to collaborate with for Clinical Trial Activity, Medical Activity, and Educational Activity.
The platform has been a unique and powerful resource for global pharma companies, including those working on COVID-19 vaccines and therapeutics. In fact, 13 of the top 20 pharmaceutical companies are currently using the platform for research and insights.
“We have created a platform for the healthcare ecosystem to connect in the same way Linkedin connected professional workers in the early 2000’s. There hasn’t been a global platform like H1 before that has connected industry to the right doctors the way H1 does,” said H1 co-founder and CEO Ariel Katz. “This next round of funding, with our excellent investment group, including Menlo who has been a great partner for us, will help us continue to become the largest healthcare professional platform and ultimately create a healthier future.”